Elsevier

Comprehensive Psychiatry

Volume 55, Issue 1, January 2014, Pages 155-164
Comprehensive Psychiatry

Assessment of psychological aspects of somatoform disorders: A study on the German version of the Health Attitude Survey (HAS)

https://doi.org/10.1016/j.comppsych.2013.08.013Get rights and content

Abstract

Objective

Given the prevalence and costs of somatoform disorders, it is important to identify and adequately treat these patients as early as possible. Instruments assessing experiences, perceptions, and behaviors of somatoform disorders are rare. In this study we evaluated the structure and validity of the German version of the Health Attitude Survey (HAS), a multidimensional self-report questionnaire for somatoform disorders.

Methods

This cross-sectional study involved 1452 participants. The sample was randomly split for independent exploratory (EFA) and confirmatory factor analyses (CFA). Each of the two samples (n1 = 726; n2 = 726) included patients with organic vertigo and current mental disorders (somatoform and other mental disorders). Somatic symptom burden was assessed using the Patient Health Questionnaire (PHQ-15).

Results

The CFA did not confirm the original HAS factor structure. The EFA revealed six factors. To enhance the fit of the model, we deleted two factors with the poorest reliability and items with low factor loadings. A modified and shortened version achieved good fit indices (CFI = 0.92; RMSEA = 0.068). It consists of 14 instead of 27 items and four scales (“dissatisfaction with care,” “frustration with ill health,” “high utilization of care,” “excessive health worry”). HAS subscales discriminated among somatoform patients and physically ill and/or patients with a mental but not somatoform disorder, controlled for age, sex and number of (comorbid) mental diagnoses, confirming its construct validity.

Conclusion

A modified shortened version of the HAS appears to be a reliable, valid, and economical instrument for assessing facets of somatoform disorders or of the recently published DSM-5 Somatic Symptom Disorder.

Introduction

Somatoform disorders are characterized by persistent or recurrent physical symptoms that cannot be explained fully by a general medical condition (e.g., Hiller et al. [1]). Patients with medically unexplained symptoms are psychologically burdened by these symptoms, have a substantially reduced quality of life, show elevated health anxiety, over-interpret minor physical symptoms as possible signs of illness, and have stable alexithymia and neuroticism [2], [3], [4], [5], [6], [7]. Moreover, they use medical care to a great extent, and thus, cause high costs for the health care system, independent of psychiatric or medical comorbidity [8], [9], [10]. Physicians often try to “normalize” medically unexplained symptoms and inadvertently offend the patient by offering insufficient explanations, leading the patient to seek additional physical examinations and medical help and to identify new physical symptoms [11]. Somatoform disorders are the most common mental disorder in primary care with prevalence rates of 10% to 26% [5], [12]. In specialized or secondary care-particularly in neurology, gynecology, and gastroenterology-up to 50% of the patients suffer from medically unexplained symptoms [13], [14].

Given the prevalence and costs of somatoform disorders, it is important to identify and adequately treat these patients as early as possible. Hence, proper assessment and screening instruments are needed for both clinical work and research. Currently there are two types of instruments assessing or screening somatoform disorders: symptom oriented and psychologically oriented. Symptom-oriented questionnaires assess bodily symptoms (e.g., dizziness, pain, and gastrointestinal complaints); examples include the Patient Health Questionnaire (PHQ-15) [5], the Screening Instrument for Somatoform Symptoms (SOMS) [15], and the Somatic Symptom Inventory [16]. Psychologically oriented questionnaires comprise specific behaviors, experiences, and perceptions of somatoform disorders, such as the Whiteley Index (WI) [2], [17], the Illness Behaviour Questionnaire (IBQ) [18], the Cognitions About Body and Health Questionnaire (CABAH) [2], the Scale for the Assessment of Illness Behaviour (SAIB) [19], and the Health Attitude Survey (HAS) [20]. Compared to the SAIB and IBQ which have been suggested for assessing different aspects of illness behavior [e.g., “verification of diagnosis” (SAIB), “expression of symptoms” (SAIB), “denial” (IBQ), or “general hypochondriasis” (IBQ)] and to the CABAH which captures cognitive aspects of somatisation and hypochondriasis (e.g., “catastrophizing interpretation of bodily complaints” or “autonomic sensations”), the Health Attitude Survey (HAS) comprises cognitions, feelings, and behaviors of patients with a somatoform disorder. In its original validation study, the HAS was shown to be a valid instrument for assessing attitudes and perceptions of patients with a somatoform disorder [20]. Furthermore, the HAS accurately differentiates between somatoform patients, patients with severe medical diseases (e.g., cancer), and controls without a somatoform disorder. In a study by Hausteiner et al. [21] the HAS predicted somatoform disorder in patients with suspected allergies. However, its psychometric properties and validity require further study.

The aim of the current study was to investigate the structure and validity of the German version of the HAS.

Section snippets

Study design and samples

This cross-sectional study was conducted between May 2010 and June 2011 and involved 1452 participants, including patients with mental disorders and physically ill patients suffering from an organic vertigo. All patients were recruited through outpatient routine care, i.e., diagnostic (first-time) appointments including the discussion of further procedure and treatment options, at either the outpatient department of the German Center for Vertigo and Balance Disorders (IFBLMU) at the University

Factor analyses

Firstly, we conducted CFA with subsample 1 (n1 = 726) to test the original factor structure allowing for six latent variables and one underlying latent construct (see Appendix, Figure A.1). The original six-factor structure with the 27 items by Noyes et al. [20] did not fit the data (CFI = .079; NFI = 0.74; RMSEA = 0.070) (see Table 2).

Therefore, we performed EFA (principal components extraction) with Varimax rotation on the 27 items of the HAS for subsample 2 (n2 = 726). The Kaiser–Meyer–Olkin measure

Discussion

Somatoform disorders are a prevalent and costly problem in the health care system. In this study our goal was to identify an adequate diagnostic and screening instrument for somatoform disorders by evaluating the structure, psychometric properties, and validity of the HAS, a multidimensional questionnaire that comprises cognitions, feelings, and behaviors of patients with a somatoform disorder [20].

Our primary finding was that a shortened and more economic version of the HAS showed good

Acknowledgment

We would like to thank Katrin Book for her help with the backward translation.

References (51)

  • R. Noyes et al.

    Health Attitude Survey—a scale for assessing somatizing patients

    Psychosomatics

    (1999)
  • T. Brandt et al.

    Vestibular paroxysmia: vascular compression of the eighth nerve?

    Lancet

    (1994)
  • R. Sykes

    Somatoform disorder and the DSM-V Workgroup's interim proposals: two central issues

    Psychosomatics

    (2012)
  • E. Wollburg et al.

    Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5

    J Psychosom Res

    (2013)
  • B. Lowe et al.

    Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment

    Gen Hosp Psychiatry

    (2008)
  • W. Hiller et al.

    Somatization in the population: from mild bodily misperceptions to disabling symptoms

    Soc Psychiatry Psychiatr Epidemiol

    (2006)
  • W. Rief et al.

    Cognitive aspects of hypochondriasis and the somatization syndrome

    J Abnorm Psychol

    (1998)
  • V. Duddu et al.

    Somatization, somatosensory amplification, attribution styles and illness behaviour: a review

    Int Rev Psychiatry.

    (2006)
  • K. Kroenke et al.

    The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

    Psychosom Med

    (2002)
  • A.J. Barsky et al.

    Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity

    Arch Gen Psychiatry

    (2005)
  • H.J. Grabe et al.

    Association of mental distress with health care utilization and costs: a 5-year observation in a general population

    Soc Psychiatry Psychiatr Epidemiol

    (2009)
  • M. Hotopf

    Preventing somatization

    Psychol Med

    (2004)
  • A.J. Barsky et al.

    Hypochondriasis: an evaluation of the DSM-III criteria in medical outpatients

    Arch Gen Psychiatry

    (1986)
  • A. Hinz et al.

    Hypochondriasis in the general population: psychometric properties and norm values of the Whiteley Index

    Diagnostica

    (2003)
  • C. Hausteiner et al.

    Psychobehavioral predictors of somatoform disorders in patients with suspected allergies

    Psychosom Med

    (2009)
  • Cited by (11)

    • Course and predictors of DSM-5 somatic symptom disorder in patients with vertigo and dizziness symptoms – A longitudinal study

      2017, Comprehensive Psychiatry
      Citation Excerpt :

      However, we could not confirm the role of affective and behavioral aspects as proposed by previous authors [13–15]. The findings toward the affective aspect of illness anxiety were unexpected as, next to its previously shown predictive role for the functional outcome, there also is previous evidence for illness anxiety differentiating between patients with somatoform disorders and other disorders like depression or anxiety [43]. Our findings for the behavioral component, which did not serve as a predictor in the multivariable regression analyses, can be seen in line with a seemingly low specificity of this component for the diagnosis of SSD [16].

    • DSM-5 somatic symptom disorder in patients with vertigo and dizziness symptoms

      2016, Journal of Psychosomatic Research
      Citation Excerpt :

      For the affective component in particular it is desirable to be able to use a scale that measures affective states in direct relation to a somatic symptom so as to guarantee a somatoform diagnosis would indeed be more appropriate than e.g. a depressive or anxiety disorder. To our knowledge there is no scale to date that meets this requirement for affective states in particular; however, a recently developed short version of the Health Attitude Survey [HAS; 48] may be appropriate to assess the psychological factors of DSM-5 more reliably. Further, the Somatic Symptom Disorder – B Criteria Scale [SSD-12; 49], an instrument to assess the psychological features of DSM-5 SSD, is currently being developed and will potentially improve the operationalization of the B-criterion.

    View all citing articles on Scopus

    Conflict of interest: The authors declare that they have no competing interests.

    Funding source: Parts of this project were supported by funds from the German Federal Ministry of Education and Research under grant code 01 EO 0901. The authors bear full responsibility for the content of this publication.

    View full text